Misplaced Pages

Micropenis: Difference between revisions

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Browse history interactively← Previous editNext edit →Content deleted Content addedVisualWikitext
Revision as of 18:10, 21 August 2008 view source198.189.243.114 (talk)No edit summary← Previous edit Revision as of 18:22, 21 August 2008 view source Ohnoitsjamie (talk | contribs)Edit filter managers, Autopatrolled, Administrators261,082 editsm Reverted edits by 198.189.243.114 (talk) to last version by ArcadianNext edit →
Line 49: Line 49:
* ] * ]
* ] * ]
* ]


==References== ==References==

Revision as of 18:22, 21 August 2008

Medical condition
Micropenis
SpecialtyMedical genetics Edit this on Wikidata

Micropenis is a medical term that describes an unusually small penis. A common criterion is a dorsal (measured on top) erect penile length of at least 2.5 standard deviations smaller than the mean penis size. The condition is usually recognized shortly after birth. The term is most often used medically when the rest of the penis, scrotum, and perineum is without ambiguity such as hypospadias.

Causes

File:Erect small5.jpg
An erect penis with the micropenis condition.

Of the abnormal conditions associated with micropenis, most are conditions of reduced prenatal androgen production or effect. Examples include abnormal testicular development (testicular dysgenesis, Klinefelter syndrome, Leydig cell hypoplasia), specific defects of testosterone or dihydrotestosterone synthesis (17,20-lyase deficiency, 5α-reductase deficiency), androgen insensitivity syndromes, inadequate pituitary stimulation (gonadotropin deficiency) or other forms of congenital hypogonadism. Micropenis can also occur as part of many genetic malformation syndromes not involving the sex chromosomes. It sometimes is a sign of congenital growth hormone deficiency or congenital hypopituitarism. Finally, several Homeobox genes have been identified which affects penis and digit size without detectable hormone abnormalities.

After evaluation to detect any of the conditions described above, micropenis can often be treated in infancy with injections of various hormones, such as human chorionic gonadotropin or testosterone.

Most eight to fourteen year old boys referred for micropenis do not have the micropenis condition. Such concerns are usually explained by one of the following:

  1. a penis concealed in suprapubic fat (extra fat around the mons pubis).
  2. a large body and frame for which a prepubertal penis simply appears too small.
  3. delayed puberty with every reason to expect good future growth.

Treatment

Hormone treatment

File:Men with micropenis.jpg
Man with micropenis, hypogonadism and gynecomastia

Growth of the penis both before birth and during childhood and puberty is strongly influenced by testosterone and, to a lesser degree, growth hormone, but their value in the treatment of micropenis is mainly limited to conditions of hormone deficiency such as hypopituitarism or hypogonadism.

Regardless of the cause of micropenis, if it is recognized in infancy, a brief course of testosterone is often prescribed (usually no more than 3 months). This will usually induce a small amount of growth, confirming the likelihood of further growth at puberty, but rarely achieves normal size. No additional testosterone is given during childhood to avoid unwanted virilization and bone maturation. (There is also some evidence that premature administration of testosterone can lead to reduced penis size in the adult.)

Testosterone treatment is resumed in adolescence only for boys with hypogonadism. Penile growth is completed at the end of puberty, similarly to the completion of height growth, and provision of extra testosterone to post-pubertal adults will produce little or no further growth.

Surgery

Because hormone treatment rarely achieves average size, a number of surgical techniques like phalloplasty for penis enlargement have been devised and performed but are not generally considered successful enough to be widely adopted and are rarely performed in childhood.

In extreme cases of micropenis, there is barely any shaft, and the glans appears to sit almost on the pubic skin. From the 1960s until the late 1970s, it was not unusual for sex reassignment and surgery to be recommended. This was especially likely if evidence suggested that response to additional testosterone and pubertal testosterone would be poor. If parents accepted, the boy would be reassigned and renamed as a girl, and surgery performed to remove the testes and construct an artificial vagina. This was based on three now questioned assumptions:

  1. gender identity and sex differences were solely a matter of social learning rather than biology.
  2. a male with a penis too small to put into a vagina could not find a satisfactory social and sexual place in society.
  3. a functionally acceptable vagina could be constructed surgically.

The center most known for this approach (Johns Hopkins Hospital) performed twelve such reassignments between 1960 and 1980, most notably, that of David Reimer, overseen by Dr. John Money. By the mid-1990s reassignment was less often offered, and all three premises had been challenged. Former subjects of such surgery, vocally dissatisfied with adult outcome, played a large part in discouraging this practice. As a result, sexual reassignment is rarely performed today for severe micropenis (although the issue of raising the child as a girl is sometimes still discussed.) Much inaccurate or exaggerated folklore on this topic is available on the internet. (See History of intersex surgery for a more complete discussion of this issue.)

See also

References

  1. Lee PA, Mazur T, Danish R; et al. (1980). "Micropenis. I. Criteria, etiologies and classification". The Johns Hopkins medical journal. 146 (4): 156–63. PMID 7366061. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
  2. Ishii T, Sasaki G, Hasegawa T, Sato S, Matsuo N, Ogata T (2004). "Testosterone enanthate therapy is effective and independent of SRD5A2 and AR gene polymorphisms in boys with micropenis". J. Urol. 172 (1): 319–24. doi:10.1097/01.ju.0000129005.84831.1e. PMID 15201804.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  3. McMahon DR, Kramer SA, Husmann DA (1995). "Micropenis: does early treatment with testosterone do more harm than good?". J. Urol. 154 (2 Pt 2): 825–9. doi:10.1016/S0022-5347(01)67175-1. PMID 7609189.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  4. Calikoglu AS (1999). "Should boys with micropenis be reared as girls?". J. Pediatr. 134 (5): 537–8. PMID 10228285.

External links

Female and male congenital anomalies of the genitalia, including intersex and DSD
Internal
Uterine malformation
Vagina
Gonads
Testicle
Ovary
Other
Vas deferens
Other
External
Penis
Other
Categories: